- Virax Biolabs Group Limited
Virax Biolabs Group Limited
30 Broadwick Street
Website
Offer Price
Offer Size
3-Year Outlook
Volatility
1st Day Turnover
$5.00
1,400,000
Positive
High
35.65%
Offering Team
Deal Managers
- Boustead Securities
Lawyers
- Loeb & Loeb, LLP
Auditors
- BF Borgers CPA PC
Pre-IPO Investors
Investors
- Google Ventures
- Intel Ventures
- Patricoff Ventures
- Kleiner Perkins
Pre-IPO Holdings(%)
- 30
- 20
- 05
- 18
Deal Highlights
We are a holding company incorporated as an exempted company under the laws of the Cayman Islands. As a holding company with no material operations of our own, we conduct our substantial operations in the United Kingdom and Hong Kong with operating subsidiaries in Singapore, China and British Virgin Islands and have been operating since 2013. We are a global innovative biotechnology group that primarily engages in sales, distribution and marketing of diagnostics test kits More
Deal Tracker
Investors
Filing
30 Jun, 2022Offer
21 Jul, 2022Look Ahead
Lock Up Expiry
21 Jan, 2023Earning
Nov 1, 2018IPO Terms
Offer Price | $5.00 |
Offer Size | 1M |